Alan L. Weiner

Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.

P. Netland, E. Sullivan, S. Robertson, 2001, American journal of ophthalmology.

Identification and characterization of the ocular hypotensive efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist, and AL-6598, a DP prostaglandin receptor agonist.

L. Desantis, N. Sharif, E. Sullivan, 2002, Survey of ophthalmology.

Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trial.

E. Sullivan, R. Fellman, J. Whitson, 2002, Ophthalmology.